Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer

K. R. Schoennemann; Lene Weber Vestermark; H. Jensen; Jon Kroll Bjerregaard; M. Krogh; C. Qvortrup; L. Tarpgaard; M. W. Ejlsmark; P. Pfeiffer

doi:10.1016/S0959-8049(16)31225-4

Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer

K. R. Schoennemann, Lene Weber Vestermark, H. Jensen, Jon Kroll Bjerregaard, M. Krogh, C. Qvortrup, L. Tarpgaard, M. W. Ejlsmark, P. Pfeiffer

KI, OUH, Research unit of Oncology (Odense)

University of Southern Denmark

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	2309
Journal	European Journal of Cancer
Volume	51
Issue number	S3
Pages (from-to)	S435
Number of pages	1
ISSN	0959-8049
DOIs	https://doi.org/10.1016/S0959-8049(16)31225-4
Publication status	Published - 2015
Event	European Cancer Congress (ECC) 2015 - Wien, Austria Duration: 25. Sep 2015 → 29. Sep 2015

Conference

Conference	European Cancer Congress (ECC) 2015
Country/Territory	Austria
City	Wien
Period	25/09/2015 → 29/09/2015

Documents & Links

10.1016/S0959-8049(16)31225-4

Cite this

Schoennemann, K. R., Weber Vestermark, L., Jensen, H., Kroll Bjerregaard, J., Krogh, M., Qvortrup, C., Tarpgaard, L., Ejlsmark, M. W., & Pfeiffer, P. (2015). Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer. European Journal of Cancer, 51(S3), S435. [2309]. https://doi.org/10.1016/S0959-8049(16)31225-4

@article{eb3e27603f9346e0ae28c04adca568aa,

title = "Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer",

author = "Schoennemann, {K. R.} and {Weber Vestermark}, Lene and H. Jensen and {Kroll Bjerregaard}, Jon and M. Krogh and C. Qvortrup and L. Tarpgaard and Ejlsmark, {M. W.} and P. Pfeiffer",

note = "European Cancer Congress 2015 Vienna, AUSTRIA 0 3; European Cancer Congress (ECC) 2015 ; Conference date: 25-09-2015 Through 29-09-2015",

year = "2015",

doi = "10.1016/S0959-8049(16)31225-4",

language = "English",

volume = "51",

pages = "S435",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

number = "S3",

}

Schoennemann, KR, Weber Vestermark, L, Jensen, H, Kroll Bjerregaard, J, Krogh, M, Qvortrup, C, Tarpgaard, L , Ejlsmark, MW & Pfeiffer, P 2015, 'Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer', European Journal of Cancer, vol. 51, no. S3, 2309, pp. S435. https://doi.org/10.1016/S0959-8049(16)31225-4

Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer. / Schoennemann, K. R.; Weber Vestermark, Lene; Jensen, H. et al.

In: European Journal of Cancer, Vol. 51, No. S3, 2309, 2015, p. S435.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS2w) administered every second week in patients with advanced gastro-esophageal cancer

AU - Schoennemann, K. R.

AU - Weber Vestermark, Lene

AU - Jensen, H.

AU - Kroll Bjerregaard, Jon

AU - Krogh, M.

AU - Qvortrup, C.

AU - Tarpgaard, L.

AU - Ejlsmark, M. W.

AU - Pfeiffer, P.

N1 - European Cancer Congress 2015 Vienna, AUSTRIA 0 3

PY - 2015

Y1 - 2015

U2 - 10.1016/S0959-8049(16)31225-4

DO - 10.1016/S0959-8049(16)31225-4

M3 - Conference abstract in journal

VL - 51

SP - S435

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - S3

M1 - 2309

T2 - European Cancer Congress (ECC) 2015

Y2 - 25 September 2015 through 29 September 2015

ER -